Instil Bio, Inc.
TIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | -$0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $9 | $7 | $5 | $1 |
| G&A Expenses | $6 | $6 | $9 | $0 |
| SG&A Expenses | $6 | $6 | $9 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $11 | $16 | $0 |
| Operating Expenses | $15 | $23 | $31 | $11 |
| Operating Income | -$15 | -$23 | -$31 | -$11 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $2 | $2 | -$0 |
| Pre-Tax Income | -$14 | -$21 | -$28 | -$12 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$21 | -$28 | -$12 |
| % Margin | – | – | – | – |
| EPS | -2.01 | -3.24 | -4.32 | -1.82 |
| % Growth | 38% | 25% | -137.4% | – |
| EPS Diluted | -2.01 | -3.24 | -4.32 | -1.82 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $2 | $2 | $1 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$12 | -$20 | -$27 | -$9 |
| % Margin | – | – | – | – |